News + Filings Transactions
|
SHAH MAHENDRA
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 04/28/2023 | Verona Pharma plc | VRNA | Grant | Share Options (Right to Buy) | 96k | $0.00 | $0 | | 04/28/2023 |
| 06/16/2022 | IMPEL PHARMACEUTICALS INC | IMPL | Grant | Stock Option (right to buy) | 12.8k | $8.65 | $110.6k | | 06/16/2022 |
| 06/10/2022 | Bolt Biotherapeutics, Inc. | BOLT | Grant | Stock Option (Right to Buy) | 25k | $1.99 | $49.8k | | 06/10/2022 |
| 03/24/2022 | Bolt Biotherapeutics, Inc. | BOLT | Grant | Stock Option (Right to Buy) | 25k | $3.03 | $75.8k | | 03/24/2022 |
| 08/09/2021 | Verona Pharma plc | VRNA | Grant | Share Options (Right to Buy) | 64k | $0.00 | $0 | | 08/09/2021 |
| 07/11/2021 | IMPEL PHARMACEUTICALS INC | IMPL | Grant | Stock Option (right to buy) | 11.5k | $9.96 | $114.5k | | 07/11/2021 |
| 02/09/2021 | Bolt Biotherapeutics, Inc. | BOLT | Exercise (in-the-money or at-the-money) | Warrant (Right to Buy) | 17.7k | $0.07 | $1.2k | By Vivo PANDA Fund, L.P. | 02/09/2021 |
| 02/09/2021 | Bolt Biotherapeutics, Inc. | BOLT | Conversion | Series B Preferred Stock | 472.3k | $0.00 | $0 | By Vivo PANDA Fund, L.P. | 02/09/2021 |
| 02/09/2021 | Bolt Biotherapeutics, Inc. | BOLT | Conversion | Series A- 1 Preferred Stock | 944.1k | $0.00 | $0 | By Vivo PANDA Fund, L.P. | 02/09/2021 |
| 02/09/2021 | Bolt Biotherapeutics, Inc. | BOLT | Sale | Common Stock | 62 | $20.00 | $1.2k | By Vivo PANDA Fund, L.P. | 02/09/2021 |
| 02/09/2021 | Bolt Biotherapeutics, Inc. | BOLT | Conversion | Common Stock | 472.3k | $0.00 | $0 | By Vivo PANDA Fund, L.P. | 02/09/2021 |
| 02/09/2021 | Bolt Biotherapeutics, Inc. | BOLT | Conversion | Common Stock | 944.1k | $0.00 | $0 | By Vivo PANDA Fund, L.P. | 02/09/2021 |
| 02/01/2021 | Verona Pharma plc | VRNA | Sale | | 10.8k | $0.99 | $10.7k | | 02/01/2021 |
| 06/11/2018 | SOLENO THERAPEUTICS INC | SLNO | Grant | Employee stock option (right to buy) | 15.9k | $2.04 | $32.5k | | 06/11/2018 |
| 04/02/2018 | Homology Medicines, Inc. | FIXX | Grant | Common Stock | 500k | $16.00 | $8M | See footnote | 04/02/2018 |
| 04/02/2018 | Homology Medicines, Inc. | FIXX | Conversion | Series B Preferred Stock | 659.7k | $0.00 | $0 | See footnote | 04/02/2018 |
| 04/02/2018 | Homology Medicines, Inc. | FIXX | Grant | Common Stock | 250k | $16.00 | $4M | See footnote | 04/02/2018 |
| 04/02/2018 | Homology Medicines, Inc. | FIXX | Conversion | Common Stock | 659.7k | $0.00 | $0 | See footnote | 04/02/2018 |
| 03/27/2018 | Homology Medicines, Inc. | FIXX | Grant | Employee stock options | 31.2k | $16.00 | $498.6k | | 03/27/2018 |
| 02/05/2018 | SOLENO THERAPEUTICS INC | SLNO | Grant | Common Stock | 3.5k | $1.73 | $6k | | 02/05/2018 |
| 07/06/2017 | SOLENO THERAPEUTICS INC | SLNO | Grant | Common Stock | 9.8k | $0.61 | $6k | | 07/06/2017 |
|